Answers are grounded in this paper and cite their sources.
Noncompliance in patients with epilepsy is a serious hindrance to successful treatment. It can result in increased healthcare costs and put both the patients and others around them at unnecessary risk. Noncompliance should be considered whenever a patient has (1) an unexpected increase in number of severity of seizures, (2) serum levels of anticonvulsant medications below the expected range, or (3) a change in medical reimbursement systems. Effective intervention strategies are based on assessment of life-style issues and possible barriers to compliance. Communication with the patient about medication regimens and the value of treatment is extremely important, and a real partnership between physician and patient is needed to set and achieve goals.
No takes yet. Share an insight, caveat, or question.
Ilo E. Leppik (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: